Region
Featured experience
Atairos investment in the parent company of the Aston Villa Football Club
We are advising Atairos on the minority investment
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
$100 million investment by consortium in Airbus subsidiary AALTO
We are advising Airbus on the transaction
Haleon $3 billion secondary placing of ordinary shares
The private placement included 700,000,000 ordinary shares
LYB International Finance II B.V. €1 Billion Guaranteed Notes Offering
Davis Polk advised the joint book-running managers on an SEC-registered offering by LYB International Finance II B.V., a…
Oesterreichische Kontrollbank $1.5 Billion Notes Offering
Davis Polk advised the underwriters on an SEC-registered offering on Schedule B by Oesterreichische Kontrollbank…
ING Groep N.V. $1.5 Billion Perpetual Additional Tier 1 Contingent Convertible Capital Securities
Davis Polk advised the joint bookrunners in connection with an SEC-registered offering of $1.5 billion aggregate principal…
Tokyo Century acquisition of Aviation Capital Group from Pacific Life
Davis Polk is advising Tokyo Century Corporation in connection with its acquisition of the remaining 75.5% interest it does…
British American Tobacco $3.5 Billion Notes Offering
Davis Polk advised the underwriters in connection with an SEC-registered offering of $1 billion aggregate principal amount…
Davis Polk Advises BBVA on Its $1 Billion SEC-Registered Preferred Securities Offering
Davis Polk advised Banco Bilbao Vizcaya Argentaria, S.A. on its SEC-registered offering of $1 billion liquidation preference…
Temenos $559 million acquisition of Kony
Davis Polk is advising Temenos AG on its $559 million acquisition of Kony Inc. and related debt financing arrangements. The…
Davis Polk Advises Tencent on Its Investment in Kuaikan World
Davis Polk is advising Tencent in connection with its investment in Kuaikan World (Cayman) Limited. Tencent subscribed…
Ocado Group consent solicitation
Davis Polk advised Ocado Group plc in connection with its successful solicitation of consents from holders of its 4.00%…
Oryzon Genomics’s Private Placement of Ordinary Shares
Davis Polk advised Oryzon Genomics, S.A. on its €20 million private placement of its ordinary shares pursuant to a capital…